0001968202-24-000064.txt : 20240213 0001968202-24-000064.hdr.sgml : 20240213 20240213160428 ACCESSION NUMBER: 0001968202-24-000064 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240209 FILED AS OF DATE: 20240213 DATE AS OF CHANGE: 20240213 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Van Plew Daniel P CENTRAL INDEX KEY: 0001411984 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19034 FILM NUMBER: 24625615 MAIL ADDRESS: STREET 1: REGENERON PHARMACEUTICALS, INC. STREET 2: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0000872589 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 133444607 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 BUSINESS PHONE: 9148477000 MAIL ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 FORMER COMPANY: FORMER CONFORMED NAME: REGENERON PHARMACEUTICALS INC DATE OF NAME CHANGE: 19930328 4 1 edgardoc.xml PRIMARY DOCUMENT X0508 4 2024-02-09 0 0000872589 REGENERON PHARMACEUTICALS, INC. REGN 0001411984 Van Plew Daniel P 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 0 1 0 0 EVP & General Mgr, Industrial 0 Common Stock 2024-02-09 4 M 0 12250 372.46 A 32628 D Common Stock 2024-02-09 4 F 0 8600 951.68 D 24028 D Common Stock 2024-02-09 4 M 0 23125 381.4 A 47153 D Common Stock 2024-02-09 4 F 0 16341 951.68 D 30812 D Common Stock 12376 I 2023 GRAT Common Stock 1084 I By 401(k) Plan Non-Qualified Stock Option (right to buy) 372.46 2024-02-09 4 M 0 12250 0.0 D 2029-12-11 Common Stock 12250 12250 D Non-Qualified Stock Option (right to buy) 381.4 2024-02-09 4 M 0 23125 0.0 D 2028-12-12 Common Stock 23125 0 D The stock option award vests in four equal annual installments, commencing one year after the date of grant. /s/**Daniel P. Van Plew 2024-02-13